Literature DB >> 11903738

Influence of Helicobacter pylori infection on the prevalence of reflux esophagitis in Japanese patients.

H Fujishiro1, K Adachi, A Kawamura, T Katsube, M Ono, M Yuki, K Amano, S Ishihara, Y Kinoshita.   

Abstract

BACKGROUND AND AIM: Reflux esophagitis is caused by esophageal motor dysfunction in patients with sufficient gastric acid secretion. Helicobacter pylori causes atrophic gastritis and influences gastric acid secretion. Hiatus hernia (HH) of the esophagus causes motor dysfunction in the lower esophagus. Therefore, this study aimed to test whether H. pylori infection, gastric mucosal atrophy and HH are predictive factors for reflux esophagitis.
METHODS: Helicobacter pylori infection was examined in 781 patients by the measurement of serum immunoglobulin (Ig)G antibody, bacteriological culture and histological examination of biopsy specimens. The prevalence of HH, endoscopically identified gastric mucosal atrophy (closed- or open-type) and reflux esophagitis were investigated by reviewing endoscopic films. Investigated patients were divided into three age groups, under 49, 50-69, and over 70 years. The prevalence of esophagitis, H. pylori infection, gastric mucosal atrophy, and HH were compared to identify the possible predictive factors for reflux esophagitis by using logistic regression analysis.
RESULTS: Sixty-nine patients with reflux esophagitis were found among the 781 investigated cases. The odds ratios of negative H. pylori infection, endoscopically identified closed-type gastric mucosal atrophy, and HH for the prevalence of reflux esophagitis were 1.342, 1.751 and 5.527, respectively. These results indicated that the presence of H. pylori infection was only a weak negative risk factor, and that HH was the most reliable endoscopic predictive factor for reflux esophagitis.
CONCLUSION: Helicobacter pylori infection is a weak negative risk factor for the prevalence of reflux esophagitis, while HH is the most reliable predictive factor.

Entities:  

Mesh:

Year:  2001        PMID: 11903738     DOI: 10.1046/j.1440-1746.2001.02618.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia.

Authors:  Yoshikazu Kinoshita; Shunji Ishihara
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

2.  Hiatal hernia and gastroesophageal flap valve as diagnostic indicators in patients with gastroesophageal reflux disease.

Authors:  Yoshikazu Kinoshita; Kyoichi Adachi
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

Review 3.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

4.  Diarrhea caused by proton pump inhibitor administration: comparisons among lansoprazole, rabeprazole, and omeprazole.

Authors:  Shino Shimura; Naoharu Hamamoto; Nagisa Yoshino; Yoshinori Kushiyama; Hirofumi Fujishiro; Yoshinori Komazawa; Kenji Furuta; Shunji Ishihara; Kyoichi Adachi; Yoshikazu Kinoshita
Journal:  Curr Ther Res Clin Exp       Date:  2012-06

Review 5.  Asymmetrical circumferential distribution of esophagogastric junctional lesions: anatomical and physiological considerations.

Authors:  Yoshikazu Kinoshita; Kenji Furuta; Kyoichi Adachi; Yuji Amano
Journal:  J Gastroenterol       Date:  2009-06-13       Impact factor: 7.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.